Market research reports, consulting: Global Market Insights Inc.

Home > Healthcare > Medical Devices > Therapeutic Devices > nasal packing devices market

Nasal Packing Devices Market Share

Report ID: GMI9472 Published Date: May 2024Report Format: PDF
Download Free Sample
Summary
Table of Content

Nasal Packing Devices Market Share

The market is highly competitive, with numerous manufacturers competing for market share. Key players often engage in product differentiation, innovation, and strategic partnerships to gain a competitive edge. Additionally, the presence of both established companies and smaller startups contributes to competitive intensity in the market. Therefore, the market exhibits a dynamic, competitive, and innovation-driven nature, shaped by regulatory requirements, technological advancements, clinical practices, and patient-centric considerations.

Nasal Packing Devices Market Companies

Some of the eminent market participants operating in the industry include:

  • Aegis Lifesciences
  • Fannin Limited
  • Boston Medical Products Inc.
  • INNOVIA MEDICAL
  • Aegis Lifesciences
  • Boston Medical Products Inc.
  • Cook
  • FABCO
  • Fannin Limited
  • INNOVIA MEDICAL
  • Lohmann & Rauscher GmbH & Co. KG
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Network Medical Products Ltd.
  • Olympus Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Summit Medical LLC.
  • Teleflex Incorporated
Author: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :

How big is the nasal packing devices market?+

Industry size for nasal packing devices was worth over USD 190.7 million in 2023 and is projected to expand at 5.2% CAGR from 2024 to 2032, owing to the rising prevalence of nasal conditions, such as chronic sinusitis, nasal trauma, and nasal tumors.

Why is the demand for nasal packing injectables on the rise?+

The injectables product segment in the nasal packing devices industry is projected to reach USD 67.8 million by 2032, due to their ability to offer targeted and controlled delivery of packing material directly into the nasal cavity.

Why is the use of bioresorbable nasal packing devices rising?+

The bioresorbable type segment in the nasal packing devices industry recorded USD 82.4 million in 2023, driven by their ability to provide temporary support and hemostasis within the nasal cavity following surgery or trauma.

What factors are driving nasal packing devices market growth in U.S.?+

U.S. industry is anticipated to record USD 107.5 million by 2032, led by the growing adoption of nasal implants, nasal surgeries, ongoing R&D efforts, and the integration of advanced technologies.

Nasal Packing Devices Market Scope

Related Reports

Buy Now

Premium Report Details

Download Free Sample